TR-115

N/A

Report date: 2023/02/26 21:49:48
NME

Base Information

Drug NameTR-115
Drug Alias NameTR115TR-115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitors
TargetsHistone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsSolid tumoursLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTarapeutics Science Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTarapeutics Science Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A